Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion type Assertion NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_head.
- NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_provenance.
- NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion evidence source_evidence_literature NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_provenance.
- NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion SIO_000772 10071278 NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_provenance.
- NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion wasDerivedFrom befree-20150227 NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_provenance.
- NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion wasGeneratedBy ECO_0000203 NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_provenance.